nuclear factor kappa B subunit 1 ; Homo sapiens

8 Article(s)
Pub. Year
#Total Relationships
1 34473771 Nafamostat mesilate, a nuclear factor kappa B inhibitor, enhances the antitumor action of radiotherapy on gallbladder cancer cells. 2021 4
2 29863120 Glycogen synthase kinase-3β activity plays a key role in the antitumor effect of nafamostat mesilate in pancreatic cancer cells. 2018 Jan 2
3 30336548 Nafamostat Mesilate Enhances the Radiosensitivity and Reduces the Radiation-Induced Invasive Ability of Colorectal Cancer Cells. 2018 Oct 17 4
4 26546875 Dual inhibition of nuclear factor kappa-B and Mdm2 enhance the antitumor effect of radiation therapy for pancreatic cancer. 2016 Jan 28 1
5 27322737 Inhibition of the NF-κB pathway by nafamostat mesilate suppresses colorectal cancer growth and metastasis. 2016 Sep 28 3
6 22806547 Inhibition of nuclear factor-κB enhances the antitumor effect of paclitaxel against gastric cancer with peritoneal dissemination in mice. 2013 Jan 2
7 23219147 Inhibition of nuclear factor kappa-B enhances the antitumor effect of combination treatment with tumor necrosis factor-alpha gene therapy and gemcitabine for pancreatic cancer in mice. 2013 Feb 1
8 21484229 Nafamostat mesilate can prevent adhesion, invasion and peritoneal dissemination of pancreatic cancer thorough nuclear factor kappa-B inhibition. 2011 Sep 3